Cite
HARVARD Citation
Kurtti, A. et al. (2020). Obesity is not strongly associated with increased risk for febrile neutropenia during levofloxacin prophylaxis in patients with hematological malignancies receiving intermediate-risk myelosuppressive chemotherapy. Journal of oncology pharmacy practice. pp. 1301-1305. [Online].